Eric Assénat

23.9k citations
178 papers · 10.6k · 3 hit papers · h-index 38

Impact in

  • Oncology top 0.1%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers
  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 29
    • Pancreatic and Hepatic Oncology Research 29
    • Cancer Treatment and Pharmacology 10
    • Hepatocellular Carcinoma Treatment and Prognosis 51

Eric Assénat

172 papers receiving 10.4k citations

Eric Assénat's Hit Papers

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma 2023 · 153 citations
1530+5+10Years since publication10002.0k3.0k4.0k5.0k

Peers

Eric Assénat
Comparison fields: 5 of 130
  • Oncology 6.2k
  • Hepatology 1.4k
  • Cancer Research 1.9k
  • Pulmonary and Respiratory Medicine 1.4k
  • Pathology and Forensic Medicine 663
Replace Philip A. Philip with:
Philip A. Philip United States
Bassel F. El‐Rayes United States
Jean‐Luc Van Laethem Belgium
Shoji Nakamori Japan
Rosine Guimbaud France
Arié Figer Israel
Andrea Cercek United States
Thomas H. Cartwright United States
Howard S. Höchster United States
Jean‐Baptiste Bachet France
Eric Assénat relative to Philip A. Philip United States Philip A. Philip's profile →
Citations per field
00.5×1.5×2.4×
Philip A. Philip · 1×
Citations per year

Countries citing papers authored by Eric Assénat

Since Specialization
Citations

This map shows the geographic impact of Eric Assénat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Assénat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Assénat more than expected).

Fields of papers citing papers by Eric Assénat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Assénat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Assénat. The network helps show where Eric Assénat may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric Assénat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Assénat Line = papers co-authored together Eric Assénat links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.

#Work
1
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Hit paper breakdown →
20115700
2
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
Hit paper breakdown →
2014460
3 2015294
4 2019205
5 2017155
6
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma
Hit paper breakdown →
2023153
7 2016143
8 2016139
9 2016136
10 2004127
11 2012107
12
Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes.
200197
13 201896
14 200888
15 201782
16 201280
17 201878
18 200977
19 201772
20 201369

About Eric Assénat

Eric Assénat is a scholar working on Oncology, Hepatology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 178 papers that have together received 10.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (51 papers), Colorectal Cancer Treatments and Studies (29 papers), Pancreatic and Hepatic Oncology Research (29 papers), Cancer Genomics and Diagnostics (23 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers), Lung Cancer Treatments and Mutations (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Cancer Treatment and Pharmacology (10 papers). The work is most often cited by research in Oncology (6.2k citations), Hepatology (1.4k citations), Cancer Research (1.9k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Pathology and Forensic Medicine (663 citations). Eric Assénat has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Marc Ychou, Rosine Guimbaud, Jean‐Luc Raoul, Françoise Desseigne, Christelle de la Fouchardière, Michel Ducreux, Jean‐Baptiste Bachet, Olivier Bouché, Y. Bécouarn and Jaafar Bennouna. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Hepatology, Cancers and Digestive and Liver Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact